These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11794846)

  • 21. Neonatal lithium toxicity as a result of maternal toxicity.
    Flaherty B; Krenzelok EP
    Vet Hum Toxicol; 1997 Apr; 39(2):92-3. PubMed ID: 9080635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R; Ueda N; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of lithium dose: a mathematical alternative to the test-dose method.
    Zetin M; Garber D; De Antonio M; Schlegel A; Feureisen S; Fieve R; Jewett C; Reus V; Huey LY
    J Clin Psychiatry; 1986 Apr; 47(4):175-8. PubMed ID: 3082862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?
    Severus WE; Kleindienst N; Seemüller F; Frangou S; Möller HJ; Greil W
    Bipolar Disord; 2008 Mar; 10(2):231-7. PubMed ID: 18271901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial.
    Kleindienst N; Severus WE; Greil W
    Int Clin Psychopharmacol; 2007 May; 22(3):125-31. PubMed ID: 17414737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels and pharmacokinetics of ordinary and sustained-release lithium carbonate in manic patients during chronic dosage.
    Thornhill DP
    Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):257-61. PubMed ID: 3089950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lithium in the prophylaxis of recurrent affective disorders. Effectiveness of low plasma levels and predictors to clinical response (author's transl)].
    Faravelli C; Marchetti G; Benvenuti P; Cabras PL
    Riv Patol Nerv Ment; 1980; 101(6):261-71. PubMed ID: 6801749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three cases of severe mania successfully treated with high-dosage lithium-carbonate.
    Thau K; Meszaros K; Simhandl C
    Pharmacopsychiatry; 1991 May; 24(3):85-8. PubMed ID: 1909797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy.
    Swartz HA; Pilkonis PA; Frank E; Proietti JM; Scott J
    Bipolar Disord; 2005 Apr; 7(2):192-7. PubMed ID: 15762861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Appropriateness of therapeutic drug monitoring for lithium.
    Ratanajamit C; Soorapan S; Doang-ngern T; Waenwaisart W; Suwanchavalit L; Suwansiri S; Jantasaro S; Yanate I
    J Med Assoc Thai; 2006 Nov; 89(11):1954-60. PubMed ID: 17205880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adequate testing of lithium dose prediction.
    Swartz CM
    J Clin Psychiatry; 1994 May; 55(5):215-6. PubMed ID: 8071273
    [No Abstract]   [Full Text] [Related]  

  • 36. MMPI as a measure of subthreshold and residual psychopathology among the offspring of lithium responsive and non-responsive bipolar parents.
    Demidenko N; Grof P; Alda M; Deshauer D; Duffy A
    Bipolar Disord; 2004 Aug; 6(4):323-8. PubMed ID: 15225151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A further prospective evaluation of an equation to predict daily lithium dose.
    Terao T; Oga T; Nozaki S; Ota A; Otsubo Y; Yamamoto S; Zamami M; Okada M
    J Clin Psychiatry; 1995 May; 56(5):193-5. PubMed ID: 7737958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is lithium still worth using? An update of selected recent research.
    Baldessarini RJ; Tondo L; Hennen J; Viguera AC
    Harv Rev Psychiatry; 2002; 10(2):59-75. PubMed ID: 11897747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Successful lithium carbonate therapy for a patient with intractable and severe aplastic anemia].
    Amano I; Morii T; Yamanaka T; Tsukaguchi N; Nishikawa K; Narita N; Shimoyama T
    Rinsho Ketsueki; 1999 Jan; 40(1):46-50. PubMed ID: 10067096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of combined administration of lithium carbonate and prednisolone in neutropenias].
    Iavorkovskiĭ LL; Iavorkovskiĭ LI
    Ter Arkh; 1985; 57(7):84-8. PubMed ID: 3931275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.